investordatabase.org

Oncology investors

13 investors that name Oncology among their sectors are recorded here: 10 venture capital firms, 1 accelerator, 1 corporate venture arm and 1 undefined. Stated investment stages run from pre-seed to growth. Most are headquartered in the United States (5), Italy (2) and Belgium (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.

InvestorLayerTypeStageHeadquarters
Agent Capital, LLC
Rare Diseases · Oncology · Neurology · Immunology
Direct investor Venture capital Seed – Growth Waltham, United States
Atlas Venture
biotechnology · life sciences · therapeutics · gene therapy
Direct investor Venture capital Seed – Series A Cambridge, United States
BaseLaunch
biotech · therapeutics · oncology · immunology
Direct investor Accelerator Pre-seed – Series A Basel, Switzerland
Cancer Focus Fund
oncology · cancer therapies · immunotherapies · CAR-T
Direct investor Venture capital Unknown Houston, United States
Claris Ventures
biopharma · oncology · immunology · rare diseases
Direct investor Venture capital Seed – Series A Turin, Italy
Droia Ventures
therapeutics · oncology · genetic disease
Direct investor Venture capital Seed – Series B Mechelen, Belgium
Hadean Ventures
life sciences · healthcare · oncology · cardiovascular
Direct investor Venture capital Unknown Oslo, Norway
Hikma Ventures
digital health · life sciences · Drug Delivery · Digital Therapeutics
Direct investor Corporate venture Series A – Growth Amman, Jordan
Jeito Capital
Biopharma · Oncology · Autoimmune · Ophthalmology
Direct investor Venture capital Series A – Growth Paris, France
MPM BioImpact
biotechnology · drug development · oncology · immunology
Direct + LP Venture capital Seed – Growth Boston, United States
Panakes Partners
Life Sciences · Biotech · Medical Devices · Therapeutics
Direct investor Venture capital Seed – Series A Milan, Italy
Sunstone Life Science Ventures
life science · therapeutics · oncology · specialty pharma
Direct investor Venture capital Seed – Series B Copenhagen, Denmark
TCG Labs Soleil
oncology · autoimmune diseases
Direct investor Venture studio Seed – Series B South San Francisco, United States